White label ELPA - ClinicalTrials.eu

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1 1 1
Investigated Drugs:
- Tofacitinib Citrate
- Tofacitinib
+4
Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Alendronate Sodium Monohydrate
Study on Health, Activity, and Joint Outcomes in Patients Aged 13-69 with Severe or Moderate Hemophilia A Using Emicizumab

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemophilia A without inhibitors
Investigated Drugs:
- Emicizumab
Study of Cabozantinib and Avelumab for Patients with Advanced Neuroendocrine Tumors G3 Resistant to Standard Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Neuroendocrine carcinoma
Investigated Drugs:
- Avelumab
- Cabozantinib
Study on the Effectiveness and Safety of Hepatitis B Surface Antigen and Imiquimod in Cirrhotic Patients Unresponsive to Conventional Vaccination

Not recruiting

2 1 1 1
Investigated Diseases:
- Hepatic cirrhosis
Investigated Drugs:
- Hepatitis B Surface Antigen
- Imiquimod
Study on Vaginal Progesterone for Improving Live Birth Rates in Women with Infertility Undergoing Frozen/Thawed IVF Natural Cycles

Not recruiting

3 1 1 1
Investigated Diseases:
- Infertility
Investigated Drugs:
- Progesterone
Study of Avelumab and Lenvatinib for Children with Central Nervous System Tumors

Not recruiting

1 1 1 1
Investigated Drugs:
- Avelumab
- Lenvatinib
Study on the Effectiveness of Pembrolizumab and Lenvatinib for Patients with Resectable Mucosal Melanoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
- Lenvatinib
- Pembrolizumab
Study of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma

Not recruiting

3 1 1
Investigated Diseases:
- Squamous cell carcinoma of skin
Investigated Drugs:
- Cemiplimab
+2
Study of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
- Neoplasm malignant
Investigated Drugs:
- Entrectinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies